SEC Filings | Celldex Therapeutics

Form	Description	Filing date	View
4	Statement of changes in beneficial ownership of securities	Jun 20, 2023	View HTML 0001415889-23-010035.pdf 0001415889-23-010035.rtf 0001415889-23-010035.xls
4	Statement of changes in beneficial ownership of securities	Jun 20, 2023	View HTML 0001415889-23-010039.pdf 0001415889-23-010039.rtf 0001415889-23-010039.xls
4	Statement of changes in beneficial ownership of securities	Jun 20, 2023	View HTML 0001415889-23-010038.pdf 0001415889-23-010038.rtf 0001415889-23-010038.xls
4	Statement of changes in beneficial ownership of securities	Jun 20, 2023	View HTML 0001415889-23-010037.pdf 0001415889-23-010037.rtf 0001415889-23-010037.xls
4	Statement of changes in beneficial ownership of securities	Jun 20, 2023	View HTML 0001415889-23-010036.pdf 0001415889-23-010036.rtf 0001415889-23-010036.xls
4	Statement of changes in beneficial ownership of securities	Jun 20, 2023	View HTML 0001415889-23-010044.pdf 0001415889-23-010044.rtf 0001415889-23-010044.xls
4	Statement of changes in beneficial ownership of securities	Jun 20, 2023	View HTML 0001415889-23-010041.pdf 0001415889-23-010041.rtf 0001415889-23-010041.xls
4	Statement of changes in beneficial ownership of securities	Jun 20, 2023	View HTML 0001415889-23-010043.pdf 0001415889-23-010043.rtf 0001415889-23-010043.xls
4	Statement of changes in beneficial ownership of securities	Jun 20, 2023	View HTML 0001415889-23-010042.pdf 0001415889-23-010042.rtf 0001415889-23-010042.xls
4	Statement of changes in beneficial ownership of securities	Jun 20, 2023	View HTML 0001415889-23-010047.pdf 0001415889-23-010047.rtf 0001415889-23-010047.xls

Data provided by Kaleidoscope.